# Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol

> **NCT01336569** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 50 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Travoprost 0.004%/timolol maleate 0.5% fixed combination

## Key facts

- **NCT ID:** NCT01336569
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2013-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01336569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01336569, "Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01336569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*